LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 29.92 | 84.90 | 771 | 2237 | 0.3446 | 0.5959 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 29.92 | 84.90 | 4 | 2237 | 0.0018 | -0.4765 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 29.92 | 84.90 | 899 | 2237 | 0.4018 | 0.6486 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 31.62 | 84.90 | 682 | 2449 | 0.2784 | 0.5366 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 31.62 | 84.90 | 740 | 2449 | 0.3021 | 0.5626 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 31.62 | 84.90 | 5 | 2449 | 0.0020 | -0.4422 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 31.62 | 84.90 | 859 | 2449 | 0.3507 | 0.6114 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 33.32 | 84.90 | 607 | 2722 | 0.2230 | 0.4817 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 33.32 | 84.90 | 656 | 2722 | 0.2410 | 0.5049 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 33.32 | 84.90 | 10 | 2722 | 0.0037 | -0.3479 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 33.32 | 84.90 | 908 | 2722 | 0.3335 | 0.6059 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 35.03 | 84.90 | 709 | 2991 | 0.2370 | 0.5114 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 35.03 | 84.90 | 762 | 2991 | 0.2547 | 0.5327 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 35.03 | 84.90 | 9 | 2991 | 0.0030 | -0.3538 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 35.03 | 84.90 | 892 | 2991 | 0.2982 | 0.5804 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 36.73 | 84.90 | 700 | 3254 | 0.2151 | 0.4934 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 36.73 | 84.90 | 740 | 3254 | 0.2274 | 0.5092 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 36.73 | 84.90 | 8 | 3254 | 0.0025 | -0.3617 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 36.73 | 84.90 | 922 | 3254 | 0.2833 | 0.5737 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 38.43 | 84.90 | 669 | 3459 | 0.1934 | 0.4710 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 38.43 | 84.90 | 706 | 3459 | 0.2041 | 0.4859 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 38.43 | 84.90 | 11 | 3459 | 0.0032 | -0.3175 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 38.43 | 84.90 | 851 | 3459 | 0.2460 | 0.5387 | MN20160318_Q02 | G16 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 40.14 | 84.90 | 740 | 3682 | 0.2010 | 0.4890 | MN20160318_Q02 | E08 |
| MCF 10A-H2B-mCherry | Neratinib | 0.31623 | 40.14 | 84.90 | 763 | 3682 | 0.2072 | 0.4974 | MN20160318_Q02 | E08 |